PlGF (Placental Growth Factor) Testing in Clinical Practice: Evidence From a Canadian Tertiary Maternity Referral Center

Hypertension. 2021 Jun;77(6):2057-2065. doi: 10.1161/HYPERTENSIONAHA.121.17047. Epub 2021 Apr 12.

Kelsey McLaughlin^{1

2

3}, John W Snelgrove¹, Melanie C Audette^{1

2}, Atif Syed⁴, Sebastian R Hobson¹, Rory C Windrim¹, Nir Melamed⁵, Sergio Carmona⁴, John C Kingdom^{1

2}

¹ Department of Obstetrics and Gynaecology, Division of Maternal-Fetal Medicine (K.M., J.W.S., M.C.A., S.R.H., R.C.W., S.C., J.C.K.), Sinai Health System, Toronto, Canada.
² The Research Centre for Women's and Infants' Health, Lunenfeld-Tanenbaum Research Institute (K.M., M.C.A., J.C.K.), Sinai Health System, Toronto, Canada.
³ Division of Cardiology, Department of Internal Medicine (K.M.), Sinai Health System, Toronto, Canada.
⁴ Information Services (A.D., S.C.), Sinai Health System, Toronto, Canada.
⁵ Department of Obstetrics and Gynaecology, Division of Maternal-Fetal Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada (N.M.).

Abstract

[Figure: see text].

Keywords: hypertension; placental growth factor; preeclampsia; pregnancy outcomes; stillbirth.